Aptose shareholders approve continuance to Alberta and Hanmi acquisition arrangement

Aptose Biosciences Inc.

Continuance from CBCA to Alberta approved with 92.42% votes in favor.
Arrangement with Hanmi (HS North America Ltd.) approved with 84.87% votes in favor.
Arrangement announced Nov 19, 2025; Hanmi to acquire all outstanding shares not already owned.
Special meeting held March 31, 2026; all items passed.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.